{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:48:48Z","timestamp":1792180128027,"version":"4.4.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008001","name":"Universit\u00e4t zu K\u00f6ln","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","award":["PJA 20141201790"],"award-info":[{"award-number":["PJA 20141201790"]}],"id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Matrix Biology Plus"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.mbplus.2020.100021","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T18:49:04Z","timestamp":1579546144000},"page":"100021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Loss of Tenascin-X expression during tumor progression: A new pan-cancer marker"],"prefix":"10.1016","volume":"6-7","author":[{"given":"Sophie","family":"Liot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Aubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Hervieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na\u00efma El","family":"Kholti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Schalkwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Verrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Valcourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mbplus.2020.100021_bb0005","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ydbio.2009.10.026","article-title":"The extracellular matrix in development and morphogenesis: a dynamic view","volume":"341","author":"Rozario","year":"2010","journal-title":"Dev. Biol."},{"issue":"2","key":"10.1016\/j.mbplus.2020.100021_bb0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005116","article-title":"Genetic analyses of integrin signaling","volume":"3","author":"Wickstr\u00f6m","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"11","key":"10.1016\/j.mbplus.2020.100021_bb0015","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/ijc.23173","article-title":"Inflammation and cancer: an ancient link with novel potentials","volume":"121","author":"Hussain","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mbplus.2020.100021_bb0020","series-title":"The Cell","author":"Cooper","year":"2000"},{"issue":"2","key":"10.1016\/j.mbplus.2020.100021_bb0025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1124\/pr.109.001289","article-title":"Extracellular matrix molecules: potential targets in pharmacotherapy","volume":"61","author":"J\u00e4rvel\u00e4inen","year":"2009","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.mbplus.2020.100021_bb0030","first-page":"209","article-title":"The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer","volume":"6","author":"Bremnes","year":"2011","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer"},{"key":"10.1016\/j.mbplus.2020.100021_bb0035","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.matbio.2017.12.003","article-title":"Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts","volume":"67","author":"Avery","year":"2018","journal-title":"Matrix Biol."},{"issue":"2","key":"10.1016\/j.mbplus.2020.100021_bb0040","first-page":"98","article-title":"The distribution of secondary growths in cancer of the breast. 1889","volume":"8","author":"Paget","year":"1989","journal-title":"Cancer Metastasis Rev."},{"issue":"6","key":"10.1016\/j.mbplus.2020.100021_bb0045","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: the \u2018seed and soil\u2019 hypothesis revisited","volume":"3","author":"Fidler","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.mbplus.2020.100021_bb0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/PAP.0000000000000219","article-title":"Paget\u2019s \u2018seed and soil\u2019 theory of cancer metastasis: an idea whose time has come","volume":"26","author":"Akhtar","year":"2019","journal-title":"Adv. Anat. Pathol."},{"issue":"11","key":"10.1016\/j.mbplus.2020.100021_bb0055","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1158\/1541-7786.MCR-12-0307","article-title":"Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue","volume":"10","author":"Karagiannis","year":"2012","journal-title":"Mol. Cancer Res. MCR"},{"issue":"1","key":"10.1016\/j.mbplus.2020.100021_bb0060","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1373\/clinchem.2012.185363","article-title":"Targeting the tumor microenvironment for cancer therapy","volume":"59","author":"Sounni","year":"2013","journal-title":"Clin. Chem."},{"issue":"12","key":"10.1016\/j.mbplus.2020.100021_bb0065","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.15252\/embr.201439246","article-title":"The extracellular matrix modulates the hallmarks of cancer","volume":"15","author":"Pickup","year":"2014","journal-title":"EMBO Rep."},{"issue":"2","key":"10.1016\/j.mbplus.2020.100021_bb0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mbplus.2020.100021_bb0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2015.11.001","article-title":"Extracellular matrix structure","volume":"97","author":"Theocharis","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mbplus.2020.100021_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2018.08.007","article-title":"Matrix modeling and remodeling: a biological interplay regulating tissue homeostasis and diseases","volume":"75\u201376","author":"Karamanos","year":"2019","journal-title":"Matrix Biol."},{"issue":"3","key":"10.1016\/j.mbplus.2020.100021_bb0085","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/1547691X.2012.723767","article-title":"Microenvironment and tumor progression of melanoma: new therapeutic prospectives","volume":"10","author":"Botti","year":"2013","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.mbplus.2020.100021_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2019.00060","article-title":"Cancer-associated fibroblasts build and secure the tumor microenvironment","volume":"7","author":"Liu","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.mbplus.2020.100021_bb0095","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pharmthera.2016.09.002","article-title":"Matrix reloaded: CCN, tenascin and SIBLING group of matricellular proteins in orchestrating cancer hallmark capabilities","volume":"168","author":"Thakur","year":"2016","journal-title":"Pharmacol. Ther."},{"issue":"1\u20132","key":"10.1016\/j.mbplus.2020.100021_bb0100","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4161\/19336918.2014.994893","article-title":"Tenascin-X: beyond the architectural function","volume":"9","author":"Valcourt","year":"2015","journal-title":"Cell Adhes. Migr."},{"issue":"5","key":"10.1016\/j.mbplus.2020.100021_bb0105","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004960","article-title":"Tenascins and the importance of adhesion modulation","volume":"3","author":"Chiquet-Ehrismann","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.mbplus.2020.100021_bb0110","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.matbio.2014.01.007","article-title":"Tenascins in stem cell niches","volume":"37","author":"Chiquet-Ehrismann","year":"2014","journal-title":"Matrix Biol."},{"issue":"23","key":"10.1016\/j.mbplus.2020.100021_bb0115","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1242\/jcs.190546","article-title":"Tenascin-C at a glance","volume":"129","author":"Midwood","year":"2016","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.mbplus.2020.100021_bb0120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.matbio.2019.07.001","article-title":"Tenascin-C increases lung metastasis by impacting blood vessel invasions","volume":"83","author":"Sun","year":"2019","journal-title":"Matrix Biol."},{"issue":"9","key":"10.1016\/j.mbplus.2020.100021_bb0125","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/bjc.2017.291","article-title":"Tenascin C in colorectal cancer stroma is a predictive marker for liver metastasis and is a potent target of miR-198 as identified by microRNA analysis","volume":"117","author":"Murakami","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"28","key":"10.1016\/j.mbplus.2020.100021_bb0130","doi-asserted-by":"crossref","first-page":"E5625","DOI":"10.1073\/pnas.1707054114","article-title":"Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival","volume":"114","author":"Gocheva","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.mbplus.2020.100021_bb0135","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bbrc.2017.03.021","article-title":"Tenascin-C is a potential cancer-associated fibroblasts marker and predicts poor prognosis in prostate cancer","volume":"486","author":"Ni","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.mbplus.2020.100021_bb0140","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.yexmp.2017.02.012","article-title":"Tenascin C is a prognostic determinant and potential cancer-associated fibroblasts marker for breast ductal carcinoma","volume":"102","author":"Yang","year":"2017","journal-title":"Exp. Mol. Pathol."},{"issue":"1\u20132","key":"10.1016\/j.mbplus.2020.100021_bb0145","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/19336918.2015.1008331","article-title":"Tenascin C in metastasis: a view from the invasive front","volume":"9","author":"Lowy","year":"2015","journal-title":"Cell Adhes. Migr."},{"issue":"2","key":"10.1016\/j.mbplus.2020.100021_bb0150","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014045","article-title":"Tenascin-C expression is significantly associated with the progression and prognosis in gastric GISTs","volume":"98","author":"Shen","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.mbplus.2020.100021_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2019.00053","article-title":"The expression and possible functions of Tenascin-W during development and disease","volume":"7","author":"Tucker","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"issue":"19","key":"10.1016\/j.mbplus.2020.100021_bb0160","doi-asserted-by":"crossref","first-page":"9169","DOI":"10.1158\/0008-5472.CAN-07-0666","article-title":"Tenascin-W is a novel marker for activated tumor stroma in low-grade human breast cancer and influences cell behavior","volume":"67","author":"Degen","year":"2007","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.mbplus.2020.100021_bb0165","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1002\/ijc.23417","article-title":"Tenascin-W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients","volume":"122","author":"Degen","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.mbplus.2020.100021_bb0170","first-page":"778","article-title":"Tenascin-W is a specific marker of glioma-associated blood vessels and stimulates angiogenesis in vitro","volume":"24","author":"Martina","year":"2010","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"issue":"2","key":"10.1016\/j.mbplus.2020.100021_bb0175","doi-asserted-by":"crossref","first-page":"187","DOI":"10.7150\/ijbs.8.187","article-title":"The adhesion modulating properties of tenascin-W","volume":"8","author":"Brellier","year":"2012","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.mbplus.2020.100021_bb0180","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/(SICI)1097-010X(19980201)280:2<152::AID-JEZ6>3.0.CO;2-N","article-title":"The distribution of tenascin-R in the developing avian nervous system","volume":"280","author":"Derr","year":"1998","journal-title":"J. Exp. Zool."},{"issue":"5","key":"10.1016\/j.mbplus.2020.100021_bb0185","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1083\/jcb.120.5.1237","article-title":"Molecular characterization and in situ mRNA localization of the neural recognition molecule J1-160\/180: a modular structure similar to tenascin","volume":"120","author":"Fuss","year":"1993","journal-title":"J. Cell Biol."},{"issue":"12","key":"10.1016\/j.mbplus.2020.100021_bb0190","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1523\/JNEUROSCI.17-12-04642.1997","article-title":"Tenascin-R is an intrinsic autocrine factor for oligodendrocyte differentiation and promotes cell adhesion by a sulfatide-mediated mechanism","volume":"17","author":"Pesheva","year":"1997","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.mbplus.2020.100021_bb0195","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jnr.1055","article-title":"Tenascin-R is expressed by Schwann cells in the peripheral nervous system","volume":"64","author":"Probstmeier","year":"2001","journal-title":"J. Neurosci. Res."},{"issue":"1\u20132","key":"10.1016\/j.mbplus.2020.100021_bb0200","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/19336918.2015.1008333","article-title":"Transcriptional regulation of tenascin genes","volume":"9","author":"Chiovaro","year":"2015","journal-title":"Cell Adhes. Migr."},{"issue":"9","key":"10.1016\/j.mbplus.2020.100021_bb0205","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.biocel.2012.05.009","article-title":"Tenascin-R: role in the central nervous system","volume":"44","author":"Anlar","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"12","key":"10.1016\/j.mbplus.2020.100021_bb0210","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1002\/cne.22632","article-title":"Spatiotemporal distribution of tenascin-R in the developing human cerebral cortex parallels neuronal migration","volume":"519","author":"El Ayachi","year":"2011","journal-title":"J. Comp. Neurol."},{"issue":"1","key":"10.1016\/j.mbplus.2020.100021_bb0215","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1083\/jcb.122.1.265","article-title":"Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B","volume":"122","author":"Bristow","year":"1993","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.mbplus.2020.100021_bb0220","first-page":"491","article-title":"Embryonic expression of tenascin-X suggests a role in limb, muscle, and heart development","volume":"203","author":"Burch","year":"1995","journal-title":"Dev. Dyn. Off. Publ. Am. Assoc. Anat."},{"issue":"26","key":"10.1016\/j.mbplus.2020.100021_bb0225","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1016\/j.febslet.2006.10.037","article-title":"A model of tenascin-X integration within the collagenous network","volume":"580","author":"Lethias","year":"2006","journal-title":"FEBS Lett."},{"issue":"Pt 8","key":"10.1016\/j.mbplus.2020.100021_bb0230","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1242\/jcs.109.8.2069","article-title":"Tenascin-X expression in tumor cells and fibroblasts: glucocorticoids as negative regulators in fibroblasts","volume":"109","author":"Sakai","year":"1996","journal-title":"J. Cell Sci."},{"issue":"5","key":"10.1016\/j.mbplus.2020.100021_bb0235","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s004010050636","article-title":"Differential expression of tenascin-C and tenascin-X in human astrocytomas","volume":"93","author":"Hasegawa","year":"1997","journal-title":"Acta Neuropathol. (Berl.)"},{"issue":"2 Pt 1","key":"10.1016\/j.mbplus.2020.100021_bb0240","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1158\/1078-0432.CCR-06-0182","article-title":"Microarray-based identification of tenascin C and tenascin XB, genes possibly involved in tumorigenesis associated with neurofibromatosis type 1","volume":"13","author":"L\u00e9vy","year":"2007","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"issue":"2\u20133","key":"10.1016\/j.mbplus.2020.100021_bb0245","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0304-4165(00)00158-6","article-title":"Opposite regulation of tenascin-C and tenascin-X in MeLiM swine heritable cutaneous malignant melanoma","volume":"1524","author":"Geffrotin","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.mbplus.2020.100021_bb0250","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3802\/jgo.2008.19.2.139","article-title":"Tenascin-X and leukemia inhibitory factor receptor are down-regulated in leiomyoma compared with normal myometrium","volume":"19","author":"Lee","year":"2008","journal-title":"J. Gynecol. Oncol."},{"issue":"20","key":"10.1016\/j.mbplus.2020.100021_bb0255","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1158\/1078-0432.CCR-06-1059","article-title":"Gene expression signatures differentiate ovarian\/peritoneal serous carcinoma from diffuse malignant peritoneal mesothelioma","volume":"12","author":"Davidson","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.mbplus.2020.100021_bb0260","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1097\/PAS.0b013e3181b6bde3","article-title":"Tenascin-X is a novel diagnostic marker of malignant mesothelioma","volume":"33","author":"Yuan","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.mbplus.2020.100021_bb0265","doi-asserted-by":"crossref","first-page":"627","DOI":"10.21873\/anticanres.13156","article-title":"Tenascin XB is a novel diagnostic marker for malignant mesothelioma","volume":"39","author":"Nakayama","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.mbplus.2020.100021_bb0270","doi-asserted-by":"crossref","first-page":"208017","DOI":"10.1155\/2015\/208017","article-title":"Secretome identifies Tenascin-X as a potent marker of ovarian cancer","volume":"2015","author":"Kramer","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"8","key":"10.1016\/j.mbplus.2020.100021_bb0275","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia N. Y. N"},{"issue":"14","key":"10.1016\/j.mbplus.2020.100021_bb0280","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1200\/JCO.2004.05.158","article-title":"Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy","volume":"22","author":"Yu","year":"2004","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"16","key":"10.1016\/j.mbplus.2020.100021_bb0285","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa002939","article-title":"A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency","volume":"345","author":"Schalkwijk","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.mbplus.2020.100021_bb0290","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-5768-0","article-title":"A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic\/prognostic potential","volume":"19","author":"Gobin","year":"2019","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.mbplus.2020.100021_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-06654-8","article-title":"TGF-\u03b2-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure","volume":"9","author":"Chakravarthy","year":"2018","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.mbplus.2020.100021_bb0300","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"The molecular taxonomy of primary prostate cancer","volume":"163","author":"Cancer Genome Atlas Research Network","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.mbplus.2020.100021_bb0305","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ccell.2017.11.018","article-title":"Genomic and epigenomic profiling of high-risk intestinal metaplasia reveals molecular determinants of progression to gastric cancer","volume":"33","author":"Huang","year":"2018","journal-title":"Cancer Cell"},{"issue":"16","key":"10.1016\/j.mbplus.2020.100021_bb0310","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1007\/s00018-019-03182-6","article-title":"Demystifying the extracellular matrix and its proteolytic remodeling in the brain: structural and functional insights","volume":"76","author":"Krishnaswamy","year":"2019","journal-title":"Cell. Mol. Life Sci. CMLS"},{"issue":"1","key":"10.1016\/j.mbplus.2020.100021_bb0315","article-title":"Subtypes of ovarian cancer and ovarian cancer screening","volume":"7","author":"Koshiyama","year":"2017","journal-title":"Diagn. Basel Switz."},{"issue":"10177","key":"10.1016\/j.mbplus.2020.100021_bb0320","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet Lond. Engl."},{"issue":"4","key":"10.1016\/j.mbplus.2020.100021_bb0325","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1083\/jcb.123.4.1037","article-title":"Downregulation of tenascin expression by glucocorticoids in bone marrow stromal cells and in fibroblasts","volume":"123","author":"Ekblom","year":"1993","journal-title":"J. Cell Biol."},{"issue":"11","key":"10.1016\/j.mbplus.2020.100021_bb0330","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/hmg\/5.11.1749","article-title":"Alternate promoters and alternate splicing of human tenascin-X, a gene with 5\u2032 and 3\u2032 ends buried in other genes","volume":"5","author":"Speek","year":"1996","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.mbplus.2020.100021_bb0335","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1006\/geno.2002.6852","article-title":"Localization and analysis of the principal promoter for human tenascin-X","volume":"80","author":"Wijesuriya","year":"2002","journal-title":"Genomics"},{"issue":"14","key":"10.1016\/j.mbplus.2020.100021_bb0340","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/j.yexcr.2008.05.019","article-title":"Induction of truncated form of tenascin-X (XB-S) through dissociation of HDAC1 from SP-1\/HDAC1 complex in response to hypoxic conditions","volume":"314","author":"Kato","year":"2008","journal-title":"Exp. Cell Res."},{"issue":"1\u20132","key":"10.1016\/j.mbplus.2020.100021_bb0345","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11010-008-9898-y","article-title":"Truncated form of tenascin-X, XB-S, interacts with mitotic motor kinesin Eg5","volume":"320","author":"Endo","year":"2009","journal-title":"Mol. Cell. Biochem."},{"issue":"8","key":"10.1016\/j.mbplus.2020.100021_bb0350","doi-asserted-by":"crossref","first-page":"13993","DOI":"10.3390\/ijms150813993","article-title":"Current status of long non-coding RNAs in human cancer with specific focus on colorectal cancer","volume":"15","author":"Smolle","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.mbplus.2020.100021_bb0355","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3390\/ijms17040573","article-title":"Current insights into long non-coding RNAs in renal cell carcinoma","volume":"17","author":"Seles","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.mbplus.2020.100021_bb0360","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17091485","article-title":"Current status of long non-coding RNAs in human breast cancer","volume":"17","author":"Cerk","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.mbplus.2020.100021_bb0365","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1111\/jcmm.14161","article-title":"LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K\/Akt signalling pathway","volume":"23","author":"Yan","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"12","key":"10.1016\/j.mbplus.2020.100021_bb0370","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1046\/j.1365-2443.2001.00482.x","article-title":"Tumour invasion and metastasis are promoted in mice deficient in tenascin-X","volume":"6","author":"Matsumoto","year":"2001","journal-title":"Genes Cells Devoted Mol. Cell. Mech."},{"issue":"9","key":"10.1016\/j.mbplus.2020.100021_bb0375","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1349-7006.2002.tb02472.x","article-title":"Invasion of melanoma in double knockout mice lacking tenascin-X and tenascin-C","volume":"93","author":"Matsumoto","year":"2002","journal-title":"Jpn. J. Cancer Res. Gann"},{"issue":"11","key":"10.1016\/j.mbplus.2020.100021_bb0380","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1248\/bpb.25.1472","article-title":"Adhesive defect in extracellular matrix Tenascin-X-null fibroblasts: a possible mechanism of tumor invasion","volume":"25","author":"Minamitani","year":"2002","journal-title":"Biol. Pharm. Bull."}],"container-title":["Matrix Biology Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590028520300028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590028520300028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:41:22Z","timestamp":1788795682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590028520300028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":76,"alternative-id":["S2590028520300028"],"URL":"https:\/\/doi.org\/10.1016\/j.mbplus.2020.100021","relation":{},"ISSN":["2590-0285"],"issn-type":[{"value":"2590-0285","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of Tenascin-X expression during tumor progression: A new pan-cancer marker","name":"articletitle","label":"Article Title"},{"value":"Matrix Biology Plus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mbplus.2020.100021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100021"}}